SI-BONE, Inc. (SIBN)
18.30
-0.12
(-0.62%)
USD |
NASDAQ |
Sep 10, 16:00
18.30
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Enterprise Value : 719.73M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 719.73M |
| September 08, 2026 | 729.12M |
| September 04, 2026 | 723.75M |
| September 03, 2026 | 730.01M |
| September 02, 2026 | 753.25M |
| September 01, 2026 | 742.52M |
| August 31, 2026 | 746.99M |
| August 28, 2026 | 755.49M |
| August 27, 2026 | 755.04M |
| August 26, 2026 | 765.32M |
| August 25, 2026 | 770.24M |
| August 24, 2026 | 767.11M |
| August 21, 2026 | 789.01M |
| August 20, 2026 | 767.56M |
| August 19, 2026 | 786.78M |
| August 18, 2026 | 752.36M |
| August 17, 2026 | 732.24M |
| August 14, 2026 | 742.97M |
| August 13, 2026 | 743.87M |
| August 12, 2026 | 746.10M |
| August 11, 2026 | 737.16M |
| August 10, 2026 | 738.95M |
| August 07, 2026 | 728.67M |
| August 06, 2026 | 707.66M |
| August 05, 2026 | 703.19M |
| Date | Value |
|---|---|
| August 04, 2026 | 721.07M |
| August 03, 2026 | 721.52M |
| July 31, 2026 | 690.68M |
| July 30, 2026 | 700.96M |
| July 29, 2026 | 721.07M |
| July 28, 2026 | 698.27M |
| July 27, 2026 | 658.94M |
| July 24, 2026 | 639.72M |
| July 23, 2026 | 633.02M |
| July 22, 2026 | 643.74M |
| July 21, 2026 | 658.49M |
| July 20, 2026 | 662.07M |
| July 17, 2026 | 673.69M |
| July 16, 2026 | 688.89M |
| July 15, 2026 | 667.88M |
| July 14, 2026 | 652.68M |
| July 13, 2026 | 694.70M |
| July 10, 2026 | 681.74M |
| July 09, 2026 | 675.48M |
| July 08, 2026 | 651.79M |
| July 07, 2026 | 670.12M |
| July 06, 2026 | 687.10M |
| July 02, 2026 | 661.62M |
| July 01, 2026 | 647.77M |
| June 30, 2026 | 626.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 209.75B |
| AngioDynamics, Inc. | 595.94M |
| Alphatec Holdings, Inc. | 1.881B |
| AtriCure, Inc. | 2.604B |
| Baxter International, Inc. | 19.29B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.088M |
| Revenue (Quarterly) | 56.01M |
| Total Expenses (Quarterly) | 60.10M |
| EPS Diluted (Quarterly) | -0.0919 |
| Gross Profit Margin (Quarterly) | 79.54% |
| Profit Margin (Quarterly) | -7.30% |
| Earnings Yield | -1.83% |
| Normalized Earnings Yield | -1.826 |